Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

G Bjelakovic, D Nikolova, LL Gluud… - Cochrane database …, 2012 - cochranelibrary.com
Antioxidant supplements for prevention of mortality in healthy participants and patients with
various diseases - Bjelakovic, G - 2012 | Cochrane Library Skip to Content Cookies Our site …

First‐line drugs for hypertension

JM Wright, VM Musini, R Gill - Cochrane Database of …, 2018 - cochranelibrary.com
Background This is the first update of a review published in 2009. Sustained moderate to
severe elevations in resting blood pressure leads to a critically important clinical question …

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals

HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen… - Jama, 2001 - jamanetwork.com
ContextMicroalbuminuria is a risk factor for cardiovascular (CV) events. The relationship
between the degree of albuminuria and CV risk is unclear. ObjectivesTo estimate the risk of …

Edmund Dunstan

A Patel, S MacMahon, B Neal, L Billot - Lancet, 2000 - thelancet.com
1 Patel A; ADVANCE Collaborative Group. Effect of a fixed combination of perindopril and
indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes …

Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Heart Outcomes Prevention Evaluation … - … England Journal of …, 2000 - Mass Medical Soc
Background Angiotensin-converting–enzyme inhibitors improve the outcome among
patients with left ventricular dysfunction, whether or not they have heart failure. We assessed …

Angiotensin-converting enzyme inhibitors

NJ Brown, DE Vaughan - Circulation, 1998 - Am Heart Assoc
ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …

The association of microalbuminuria and mortality in non—insulin-dependent diabetes mellitus: a systematic overview of the literature

SF Dinneen, HC Gerstein - Archives of internal medicine, 1997 - jamanetwork.com
Objectives: To critically analyze the literature linking microalbuminuria with total and
cardiovascular mortality and cardiovascular morbidity in non—insulin—dependent diabetes …

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension

S Taddei, A Virdis, L Ghiadoni, A Magagna, A Salvetti - Circulation, 1998 - Am Heart Assoc
Background—Essential hypertension is associated with impaired endothelium-dependent
vasodilation. Inactivation of endothelium-derived nitric oxide by oxygen free radicals …

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

P Verdecchia, JA Staessen, F Angeli, G De Simone… - The Lancet, 2009 - thelancet.com
Background The level to which systolic blood pressure should be controlled in hypertensive
patients without diabetes remains unknown. We tested the hypothesis that tight control …

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

J Mathew, P Sleight, E Lonn, D Johnstone, J Pogue… - Circulation, 2001 - Am Heart Assoc
Background Electrocardiographic markers of left ventricular hypertrophy (LVH) predict poor
prognosis. We determined whether the ACE inhibitor ramipril prevents the development and …